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Extended Lumbar Drainage in Idiopathic Normal Pressure Hydrocephalus: A 
Systematic Review and Meta-Analysis of Diagnostic Test Accuracy 
 
Background: When appropriately selected, a high proportion of patients with suspected idiopathic normal 
pressure hydrocephalus (iNPH) will respond to cerebrospinal fluid diversion with a shunt. Extended 
lumbar drainage (ELD) is regarded as the most accurate test for this condition, however, varying 
estimates of its accuracy are found in the current literature. Here, we review the literature in order to 
provide summary estimates of sensitivity, specificity, positive- and negative predictive value for this test 
through meta-analysis of suitably rigorous studies. 
 
Methods: Studies involving a population of NPH patients with predominantly idiopathic aetiology 
(>80%) in which the intention of the study was to shunt patients regardless of the outcome of ELD were 
included in the review. Various literature databases were searched to identify diagnostic test accuracy 
studies addressing ELD in the diagnosis of iNPH. Those studies passing screening and eligibility were 
assessed using the QUADAS-2 tool and data extracted for bivariate random effects meta-analysis. 
 
Results: Four small studies were identified. They showed disparate results concerning diagnostic test 
accuracy. The summary estimates for sensitivity and specificity were 94% (CI 41-100%) and 85% (CI 33-
100%), respectively. The summary estimates of positive and negative predictive value were both 90% 
(CIs 65-100% and 48-100%, respectively). 
 
Conclusion: Large, rigorous studies addressing the diagnostic accuracy of ELD are lacking, and little 
robust evidence exists to support the use of ELD in diagnostic algorithms for iNPH. Therefore, a large 
cohort study, or ideally an RCT, is needed to determine best practice in selecting patients for shunt 
surgery. 
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Idiopathic normal pressure hydrocephalus (iNPH), originally described by Salomon Hakim in 
1964,1 is a progressive neurological condition characterised by ventricular enlargement 
combined with the clinical triad of gait impairment, cognitive problems and urinary dysfunction. 
The condition is highly responsive to treatment with a CSF shunt system,2–5 and the benefit 
derived from this can persist for many years.6 Prompt diagnosis and management is crucial, since 
the beneficial effect of shunt surgery declines with increasing duration of symptoms prior to 
intervention.7,8 Idiopathic NPH can be diagnostically challenging due to the non-specific nature 
of the Hakim triad, which overlaps with many other neurodegenerative disorders. This is also the 
case for ventricular enlargement, which may be a consequence of cerebral atrophy in patients 
with cognitive impairment. Limited understanding of the pathophysiological mechanism 
underlying the condition has hampered attempts to devise diagnostic tests that identify patients 
who will respond to CSF diversion. The diagnostic test currently favoured involves drainage of a 
certain volume of CSF from the lumbar subarachnoid space, with clinical assessment before and 
after (known as ‘extended lumbar drainage’ or ‘ELD’). While successful at predicting patients 
who will respond to shunt insertion, some authors have suggested that ELD may have a low 
negative predictive value,9,10 and hence there is potential for diagnostic algorithms relying upon 
it to exclude patients from an intervention that might have provided significant benefit. 
 
Here, we have completed a systematic review and meta-analysis of the accuracy of ELD (the 
index test) as a means of diagnosing iNPH. ‘Definite iNPH’ is defined by the Japanese Society 
for Neurosurgery as a diagnosis that can only be made retrospectively after response to CSF 
diversion is demonstrated.11 Therefore, the reference standard test was defined as improvement 





The following question was formulated to guide the review: “How accurate is ELD as a 
diagnostic test for iNPH in patients referred to a regional hydrocephalus clinic?” In order to 
answer this question, a set of inclusion/exclusion criteria and a search strategy were designed. A 
protocol was written in advance of the review, and the project was prospectively registered on 
the PROSPERO database (ID: CRD42018110518; available at 
https://www.crd.york.ac.uk/prospero/). 
 
To be included in the review and meta-analysis, a study must: i) have been performed on a 
population of suspected NPH patients in which either >80% were idiopathic or with iNPH 
patient data extractable from the report; ii) involve a population of patients undergoing ELD 
prior to insertion of a ventriculo-peritoneal (VP), ventriculo-atrial (VA) or lumbo-peritoneal (LP) 
shunt; iii) have been designed such that the intention of the study was to shunt all patients (rather 
than just those who improved with ELD); iv) allow the extraction of numbers of true positives, 
false positive, true negative and false negatives, or sensitivity and specificity directly. 
‘Suspected’ NPH must have been defined as involving at least one feature of the Hakim triad 
combined with imaging findings of ventriculomegaly. Studies in which a ‘qualifying’ test was 
applied to a population of suspected NPH patients prior to ELD, such that the pre-test probability 
of a successful ELD outcome was increased, were excluded. 
 
The following electronic databases were searched on 5th September 2018: Medline; Embase; 
Cochrane Library; Latin American and Caribbean Health Sciences Literature (LILACS); 
Aggressive Research Intelligence Facility (ARIF); Database of Abstracts of Reviews of Effects 
(DARE); and ClinicalTrials.gov. The following keywords were used in the search strategy: 
‘Normal pressure hydrocephalus’, ‘normotensive hydrocephalus’ and various permutations of 
‘cerebrospinal’ or ‘CSF’ together with ‘lumbar drain’ or ‘diversion’. Equivalent Spanish terms 
were used in the search of the LILACS database. No language or date limits were applied. Full 




Screening of titles/abstracts, and full-text reports, was performed in parallel by two independent 
assessors using the Covidence systematic review software (Veritas Health Innovation, 
Melbourne, Australia; available at www.covidence.org). Disagreements between the screening 
authors were resolved by dialogue, and if this was not possible, a third author held the casting 
vote. A PRISMA flow chart was created to detail the outcome of the screening process.12 The 
QUADAS-2 tool was then used to assess the risk of bias in included studies.13 Diagnostic test 
accuracy metrics were extracted independently by two authors and fidelity confirmed, to ensure 




Bivariate random effects meta-analysis of sensitivity and specificity was performed in 
WinBUGS.14–16 We assumed the following vague prior distributions: Normal(0,100) for means, 
Half-Normal(0,3) for between-study standard deviations and Uniform(-1,0) for the between-
study correlation in sensitivity and specificity. The model was also fitted in a frequentist 
framework in Stata (StataCorp LLC, College Station, TX) using the ‘Metandi’ package as a 
sensitivity analysis.17   
 
Summary estimates of sensitivity and specificity were generated with a 95% credible ellipse and 
a 95% prediction region. These results were used to generate estimates, with uncertainty, of 
positive predictive value (PPV) and negative predictive value (NPV) across a range of 
prevalences. A summary Receiver Operating Characteristic (ROC) curve was also generated, 
drawing on the equivalence of the bivariate model with the hierarchical summary ROC 
(HSROC) model.18–20 
 
Subgroup analyses and/or meta-regression using the following variables were planned if there 
was sufficient data: criteria for regarding the ELD to have demonstrated improvement, duration 
of lumbar drainage, volume drained per hour. Sensitivity analyses were also planned if there was 
a controversial study (about which the screening authors disagreed) or if QUADAS-2 identified 





The PRISMA diagram showing flow through the study is presented in Figure 1. Two hundred 
and seventy-three abstracts were identified for screening after duplicates were removed. Of 
these, 247 were excluded during abstract screening. Twenty-six reports progressed to full-text 
screening. Ten were excluded on the basis that the authors’ intention was to shunt only the ELD 
responders. A further 9 studies were excluded because their reports presented insufficient data to 
allow calculation of sensitivity and/or specificity. The reasons for exclusion of the other 7 are 
detailed in the PRISMA diagram. 
 
Four small studies (84 patients in total) passed screening and eligibility, and their characteristics 
are summarised in Table 1. All included studies were of a prospective cohort design and 
contained predominantly iNPH patients (range 88-100%). In terms of inclusion criteria, all 
studies required gait impairment as a presenting symptom and ventriculomegaly on CT or MRI. 
One study (Chen et al.21) required both gait and dementia as presenting symptoms. Most (3 out 
of 4 studies) also required a ‘normal’ opening pressure on lumbar puncture, and Haan et al.22 
required cisternography evidence of abnormal CSF flow. All the studies excluded patients with 
severe cortical atrophy (or any cortical atrophy in the case of Chen et al. and Haan et al.). 
Panagiotopoulos et al.10 and Walchenbach et al.9 also excluded patients with minimal gait 
disturbance in the context of ‘severe’ dementia. Of note, both Haan et al. and Walchenbach et al. 
excluded patients who were improving after high volume lumbar puncture. 
 
Most of the included studies conducted ELD for 5 days (range 4-5) and the mean CSF drainage 
rate was 11.6ml/hr (range 5.3-16.5). The criteria for judging the ELD test to have been 
successful was gait improvement in Walchenbach et al. and Panagiotopoulos et al.; whereas 
Chen et al. accepted improvement in any domain of the Hakim triad and Haan et al. required 
improvement in either cognitive function or urinary function in addition to gait. 
 
The reference standard test was a VP shunt in Panagiotopoulos et al. and Walchenbach et al., a 
VA shunt in Haan et al., and randomisation to a VP or LP shunt in Chen et al. The only study to 
use programmable valves was Walchenbach et al. The criteria used to judge the success of the 
 
 
ELD test and shunting were identical in all cases, except Walchenbach et al., where 
improvement in gait following shunting had to be confirmed by the patient, their family or the 
nursing team responsible for the patient’s care. Mean follow-up of shunted patients prior to a 
decision being made regarding shunt outcome was 4.3 months (range 0.25-12). 
 
Risk of bias assessment 
 
The results of the QUADAS-2 assessments are summarised in Figures 2 and 3. Only Chen et al. 
was deemed to have low risk of bias and low applicability concerns across all domains of the 
QUADAS-2 tool. The only issue of potential concern with Chen et al. was that not all patients 
received the same reference standard (they were randomised to a VP or an LP shunt). However, 
this was not felt to be sufficient to regard the study as high risk in the ‘Flow and Timing’ domain 
as the equivalence of these two interventions has been established by a recent trial.23 
 
Haan et al. was felt to have unclear risk of bias in the ‘Patient Selection’ and ‘Reference 
Standard’ domains and high applicability concerns in the ‘Patient Selection’ domain. The risk of 
bias concerns arose because of the following issues: i) lack of clarity as to whether a consecutive 
or random method of patient selection was employed or if a more biased strategy was used; ii) 
the absence of any reference to blinding the assessor of shunt outcome to the result of the ELD 
index test. The applicability concerns were based on the use of radioisotope cisternography in 
order to select patients. This test is regarded as relatively insensitive for NPH, and in one study, 
55% of patients with a normal cisternogram improved following shunting (compared to 73% 
with a typical NPH pattern, which was not statistically significant).24 
 
Panagiotopoulos et al. was also classified as ‘unclear’ risk of bias in the ‘Patient Selection’ 
domain and ‘Reference Standard’ domain because of the following issues: i) unclear means of 
patient selection, and no evidence to suggest a consecutive or random method; ii) no reference to 




Finally, Walchenbach et al. was deemed high risk of bias and high applicability concerns in the 





The observed sensitivity, specificity, PPV and NPV from each of the studies are presented in 
Table 2. Sensitivity and specificity derived from these studies are also presented graphically as a 
coupled forest plot in Figure 4, and in ROC space in Figure 5. Two of the studies (Chen et al. 
and Haan et al.) report the ELD test as ‘perfect’, i.e. no false negatives or false positives, 
however, the sample size was small in both cases (7 and 17 patients, respectively). 
Panagiotopoulos et al. also reported a high sensitivity (94%) but a significantly lower specificity 
(40%), whereas Walchenbach et al., the largest included study, suggested the reverse: a low 
sensitivity (50%) and a moderately high specificity (80%). All studies support a high PPV (88-
100%), and two studies also supported a high NPV (100%). However, Panagiotopoulos et al. and 
Walchenbach et al. suggest a lower value for NPV (67 and 36%, respectively). 
 
The summary estimates of sensitivity and specificity from the meta-analysis were 94% (95% 
credible interval [CI] 41-100%) and 85% (95% CI 33-100%), respectively (see Table 3; plotted 
in ROC space in Figure 5). The very wide CIs associated with these estimates reflect the small 
and heterogeneous nature of the included studies. The 95% prediction region for a new study 
(Figure 5) encompasses the entire ROC space. The sensitivity analysis performed in Stata gave 
very similar summary results (sensitivity 95% [CI 36-100%], specificity 86% [CI 35-99%]). 
 
Since the PPV and NPV depend on the true prevalence of NPH within the population who might 
conceivably receive the test, observed PPV and NPV are plotted against prevalence in Figure 6. 
The prevalence in the included studies varied from 53-77% which is in line with the senior 
author’s own experience, in which the prevalence of shunt responsive NPH is around 60%. 
Figure 6 also shows summary estimates of PPV and NPV calculated from the meta-analysis 
results, across all possible prevalences. At a prevalence of 60%, the summary PPV and NPV are 




Subgroup analyses and meta-regression to explore heterogeneity were not performed due to the 
small number of studies. Following the QUADAS-2 assessments, three of the four studies were 
deemed to be high risk of bias overall, and consequently a sensitivity analysis including only 
low-risk studies could not be performed (as it would have included only one study). There were 
no disagreements between the screening authors regarding the inclusion of a study that was not 
resolved by discussion between the authors; therefore, no sensitivity analysis excluding 





Many diagnostic tests have been proposed for iNPH, and most have been shown to have poor 
diagnostic accuracy.4,24–26 ELD is widely regarded as the most robust test for iNPH and several 
well-conducted studies have supported a high PPV for the test,10,21,22,26 as have observational 
cohorts in which only ELD responders were shunted.27–30 Furthermore, improvement following 
ELD has been shown to correlate well with improvement following shunt surgery.31 
Consequently, ELD may perform several roles beyond a pure diagnostic test. For instance, the 
response to ELD is useful in aiding patients’ understanding of the potential benefits of shunt 
surgery and is also useful in patients with cardiac or respiratory co-morbidities or those taking 
anticoagulant drugs who may be exposed to higher operative risks. However, although the PPV 
of ELD is high, it has been suggested that its NPV may be low,9 raising the possibility that ELD 
may not be an appropriate test to deny or deter patients from surgery. 
 
Our systematic review identified only 4 sufficiently rigorous studies addressing the diagnostic 
test accuracy of ELD. The commonest reason for exclusion of a study was failure to shunt 
patients regardless of ELD outcome, an essential characteristic for a study to report accurate 
sensitivity and specificity. Despite stringent inclusion criteria, the studies passing screening and 
eligibility reported disparate results and many had significant methodological issues, such as 
unclear selection methods and lack of blinding. 
 
Overall, the summary estimates of sensitivity and specificity suggest that ELD is a sensitive and 
relatively specific test for iNPH (sensitivity 94%, specificity 85%), but with a large amount of 
statistical uncertainty around these estimates. The only study deemed to be at low risk of bias 
and low applicability concerns in all QUADAS-2 domains (Chen et al.) estimated 100% 
sensitivity for the test, but this was based on only 7 patients. Of the three remaining studies, two 
found sensitivity to be high (94-100%), and only one (Walchenbach et al.) estimated it to be low 
(50%). The true value probably lies closer to the former estimate because Walchenbach et al. 
excluded patients who responded positively to a CSF tap test, which is likely to have removed 
true positives and hence under-estimated the sensitivity of the test. Conversely, in excluding 
 
 
patients with any form of cortical atrophy, Chen et al. and Haan et al. are likely to have over-
estimated sensitivity in their studies. 
 
Unlike sensitivity and specificity, which are fixed variables, PPV and NPV depend on the 
prevalence of shunt-responsive iNPH within the population who might conceivably receive the 
test. For instance, if a larger population with more condition-negative patients is exposed to the 
test, the PPV falls and the NPV increases. At an estimated prevalence of 60% (which is that 
observed in our senior author’s practice), both PPV and NPV were estimated at 90%, but again 
with a large amount of uncertainty due to the sparsity of evidence. The NPV rises slightly to 93% 
(CI 55-100%), with PPV unchanged, if the true prevalence is at the lower end of that observed in 
our included studies (53%); if the prevalence is at the higher end of this range (77%), the 
estimated PPV rises to 100% but the NPV falls to 81% (CIs 81-100% and 29-100%, 
respectively). 
 
A limitation common to all the included studies, except Walchenbach et al., is that none 
employed programmable valves. This reflects the historical treatment of iNPH and the belief that 
any CSF diversion is enough to treat the condition. However, clinical experience has 
demonstrated that patients may manifest a clinical response at different valve pressure settings.32 
Our current treatment paradigm is more nuanced: Programmable shunts are used, and if patients 
do not improve following shunt surgery, the setting is gradually adjusted down until 
improvement of the iNPH symptoms has reached a plateau or symptoms of over-drainage are 
encountered. Furthermore, none of the included studies confirmed the functioning of the shunt in 
patients deemed to be non-responders. These aspects of their methodology may have resulted in 
true positives being missed, and a falsely low estimate of sensitivity and PPV. A further 
methodological difference between the included studies and current practice is the duration of 
the ELD test, which was 5 days in 3 of the studies, and 4 in the other. Although practice varies 
between institutions, most would conduct the test for 3 days.26,28,29 In addition, the exclusion of 
patients with cortical atrophy in all studies is a concern, since two of these pre-date the 
description of DESH, the imaging characteristics of which may increase the probability of 
response to CSF shunting, but may historically have been mislabelled as cortical atrophy due to 
enlarged Sylvian subarachnoid spaces.  
 
 
Although outside the scope of this review, one question raised by the finding of a weak evidence 
base for ELD is whether supplementary testing (beyond clinico-radiological indicators) is 
warranted at all. ELD arose in an era of high rates of shunt complications. In the Dutch Normal 
Pressure Hydrocephalus Study in the 1990s,33 16.5% of patients required surgical intervention 
for infection or hematoma formation during the 12-month period of follow-up, whereas in the 
European Multicentre Study,34 published 15 years later, only 1.7% of patients suffered this type 
of complication. At less than 2%, it may be argued that the risks associated with a lumbar drain 
(1-5% of meningitis)9,26 is higher, or at least similar to, those of a VP shunt. The cost 
effectiveness of this strategy has already been established by an analysis based on a Monte-Carlo 
simulation,35 as well as a more recent prospective study,36 which found a 1.7 quality-adjusted life 
year (QALY) benefit in suspected iNPH patients shunted purely on clinic-radiological grounds, 
with an associated cost per QALY of €7,500. The success of a recent randomised, controlled trial 
of shunt insertion in an iNPH population selected on clinico-radiological grounds (and the fact 
that no difference in the rate of complications was observed between intervention and control 
groups) also lends support to the argument for dispensing with supplementary testing.2 However, 
it should be noted that this study was performed by experts in iNPH, who are likely to be adept at 
diagnosing the condition (and distinguishing it from potential mimics) on the basis of history and 
examination alone. It is also important to note that even if the balance does tip in favour of 
treatment decisions based on clinico-radiological indicators, it is likely that there will remain a 
role for ELD in certain circumstances, for instance, in patients in whom surgery would be high 




The results of this meta-analysis suggest a high PPV and NPV for ELD, but this should be 
interpreted with caution given the limited number of available studies, which are themselves 
small and heterogenous. Robust studies addressing the question of the diagnostic test accuracy of 
ELD are lacking and a well-designed, suitably large cohort study is required or, even better, a 
randomised controlled trial. Only the latter would establish if outcomes are enhanced by prior 
patient selection with ELD, or if procedural complications associated with shunt insertion are 
 
 
now so low that the loss of potential responders favours a treatment strategy based upon clinico-
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Figure 1. PRISMA flow diagram indicating flow of studies through screening/eligibility and 
reasons for exclusion of full-text reports. 
 
Figure 2. Visual representation of the results of the QUADAS-2 analysis (by study). 
 
Figure 3. Visual representation of the results of the QUADAS-2 analysis (by QUADAS-2 
domain). 
 
Figure 4. Coupled forest plots for included studies. TP = true positive; FP = false positive; FN = 
false negative; TN = true negative; CI = confidence interval. 
 
Figure 5. Study-specific estimates of sensitivity and specificity in Receiver Operating 
Characteristic (ROC) space, together with meta-analysis results. Black circles represent 
individual studies (diameter of the circle is proportional to the size of the study). Summary 
estimate of sensitivity/specificity is marked by the red dot. 95% credible region is delineated by a 
dashed red line, and 95% prediction region by a dotted red line. The blue line shows the 
hierarchical summary receiver-operating characteristic (HSROC) curve from the meta-analysis. 
 
Figure 6. Plot of summary PPV/NPV against prevalence. Observed PPVs from individual studies 
are represented by red stars and observed NPVs by blue dots. The ‘predicted’ summary lines for 
PPV and NPV are in red and blue, respectively, and the corresponding 95% credible intervals are 













Search date for all searches: 05.09.2018 
 
Medline 
via HDAS (1946 to present) 
1 ("normal pressure hydrocephalus" OR "normotensive hydrocephalus").ti,ab 2322 
2 "HYDROCEPHALUS, NORMAL PRESSURE"/ 2046 
3 (1 OR 2) 2800 
4 ((CSF OR "Cerebrospinal fluid" OR "Cerebro-spinal fluid" OR lumbar) ADJ (diversion 
OR drain*)).ti,ab 
2845 
5 (3 AND 4) 162 
 
Embase 
via HDAS (1974 to present) 
1 ("normal pressure hydrocephalus" OR "normotensive hydrocephalus").ti,ab 3144 
2 "NORMOTENSIVE HYDROCEPHALUS"/ 3223 
3 (1 OR 2) 3879 
4 ((CSF OR "Cerebrospinal fluid" OR "Cerebro-spinal fluid" OR lumbar) ADJ (diversion 
OR drain*)).ti,ab 
3763 
5 (3 AND 4) 241 
 
Cochrane Library databases 
via Wiley (Issue 9, 2018) 
1 ("normal pressure hydrocephalus" OR "normotensive hydrocephalus"):ti,ab,kw 85 
2 MeSH descriptor: [Hydrocephalus, Normal Pressure] explode all trees 43 
3 (1 OR 2) 90 
 
 
4 ((CSF OR "Cerebrospinal fluid" OR "Cerebro-spinal fluid" OR lumbar) next (diversion 
OR drain*)):ti,ab,kw 
160 
5 (3 AND 4) 13 
 




"normotensive hydrocephalus" OR "normal pressure hydrocephalus" OR "hidrocefalia 
normotensiva" 
2 AND drain OR drainage OR diversion OR drenaje 
 
Aggressive Research Intelligence Facility (ARIF) database 
(https://www.birmingham.ac.uk/research/activity/mds/projects/HaPS/PHEB/ARIF/databases/ind
ex.aspx) 
1 ("normotensive hydrocephalus" OR "normal pressure hydrocephalus"):ti,ab 1 
 
Database of Abstracts of Reviews of Effects (DARE) 
via CRD (https://www.crd.york.ac.uk/CRDWeb/) 
1 "normotensive hydrocephalus" OR "normal pressure hydrocephalus" 6 
 
ClinicalTrials.gov 
US National Institutes of Health (https://clinicaltrials.gov/) 
Condition or disease: "normal pressure hydrocephalus" OR "normotensive hydrocephalus" 
Other terms: 
drain OR drainage OR diversion 
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